New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure
Authors
Keywords
Aldosterone, Mineralocorticoid receptor (MR), MR antagonist, Finerenone, Chronic kidney disease (CKD)
Journal
JOURNAL OF NEPHROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-16
DOI
10.1007/s40620-019-00600-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice
- (2018) Luca De Nicola et al. JOURNAL OF NEPHROLOGY
- The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling
- (2018) Jonatan Barrera-Chimal et al. KIDNEY INTERNATIONAL
- New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention
- (2018) Patrycjusz Kolodziejczyk et al. CURRENT DRUG TARGETS
- Aldosterone Target NGAL (Neutrophil Gelatinase–Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction Through NFκB PathwayNovelty and Significance
- (2017) Ernesto Martínez-Martínez et al. HYPERTENSION
- Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury–Mediated Chronic Kidney DiseaseNovelty and Significance
- (2017) Lionel Lattenist et al. HYPERTENSION
- 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
- (2017) Peter Kolkhof et al. JOURNAL OF ENDOCRINOLOGY
- Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1
- (2017) Jonatan Barrera-Chimal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renin–angiotensin system blockade: Finerenone
- (2017) Luis M. Ruilope et al. Nephrologie & Therapeutique
- The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
- (2017) Jochen Dutzmann et al. PLoS One
- Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
- (2017) Greg H. Tesch et al. Frontiers in Pharmacology
- Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
- (2016) Andrew S. Bomback BLOOD PURIFICATION
- Cardiac Tissue Injury and Remodeling Is Dependent Upon MR Regulation of Activation Pathways in Cardiac Tissue Macrophages
- (2016) Jimmy Z. Shen et al. ENDOCRINOLOGY
- A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
- (2016) Gerasimos Filippatos et al. EUROPEAN HEART JOURNAL
- Low glomerular filtration rate and risk of myocardial infarction: A systematic review and meta-analysis
- (2016) Vishal Vashistha et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists Cause Differential Cardiac Gene Expression in Pressure Overload-induced Cardiac Hypertrophy
- (2016) Jana Grune et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology
- (2016) Vincenzo Bellizzi et al. JOURNAL OF NEPHROLOGY
- Pharmacokinetics, distribution, and disposition of esaxerenone, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist, in rats and monkeys
- (2016) Makiko Yamada et al. XENOBIOTICA
- Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arena
- (2016) Murray Epstein Kidney International Supplements
- Relation of Aortic Valve Calcium to Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort Study)
- (2015) Marie A. Guerraty et al. AMERICAN JOURNAL OF CARDIOLOGY
- Underprescription of Renin–Angiotensin System Blockers in Moderate to Severe Chronic Kidney Disease
- (2015) Shayan Shirazian et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist
- (2015) Kiyoshi Arai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
- (2015) Kiyoshi Arai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload–Induced Cardiac InjuryNovelty and Significance
- (2015) Nobuhiro Ayuzawa et al. HYPERTENSION
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1
- (2015) Larbi Amazit et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aldosterone-induced expression of ENaC-α is associated with activity of p65/p50 in renal epithelial cells
- (2015) Rongquan Chen et al. JOURNAL OF NEPHROLOGY
- Intersection of cardiovascular disease and kidney disease
- (2014) Nisha Bansal et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Emerging drugs for chronic kidney disease
- (2014) Sergio Stefoni et al. EXPERT OPINION ON EMERGING DRUGS
- Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
- (2014) Peter Kolkhof et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Aldosterone synthase inhibitors in cardiovascular and renal diseases
- (2014) P. Namsolleck et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: An emerging paradigm in diabetic nephropathy
- (2013) Thomas A. Mavrakanas et al. European Journal of Internal Medicine
- Incidence and Predictors of Postoperative Atrial Fibrillation in Kidney Transplant Recipients
- (2013) Gaetano La Manna et al. TRANSPLANTATION
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Oxidative Stress Causes Mineralocorticoid Receptor Activation in Rat Cardiomyocytes
- (2012) Miki Nagase et al. HYPERTENSION
- Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms
- (2012) Linda Shavit et al. KIDNEY INTERNATIONAL
- Aldosterone and cardiovascular disease: the heart of the matter
- (2012) B. Julie He et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Deletion of Cardiomyocyte Mineralocorticoid Receptor Ameliorates Adverse Remodeling After Myocardial Infarction
- (2011) Daniela Fraccarollo et al. CIRCULATION
- Effect of eplerenone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric chronic hemodialysis patients – a pilot study
- (2011) L. Shavit et al. CLINICAL NEPHROLOGY
- Minireview: Aldosterone and Mineralocorticoid Receptors: Past, Present, and Future
- (2010) John W. Funder ENDOCRINOLOGY
- Aldosterone and Mineralocorticoid Receptors in the Cardiovascular System
- (2010) John W. Funder PROGRESS IN CARDIOVASCULAR DISEASES
- Use of Aldosterone Antagonists in Heart Failure
- (2009) Nancy M. Albert JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Corticosteroid receptors, macrophages and cardiovascular disease
- (2009) Amanda J Rickard et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review
- (2008) Andrew S. Bomback et al. AMERICAN JOURNAL OF KIDNEY DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started